ULBP1
From Wikipedia, the free encyclopedia
UL16 binding protein 1
|
||||||||||||||
Identifiers | ||||||||||||||
Symbol(s) | ULBP1; RAET1I | |||||||||||||
External IDs | OMIM: 605697 MGI: 1925027 HomoloGene: 69396 | |||||||||||||
|
||||||||||||||
RNA expression pattern | ||||||||||||||
Orthologs | ||||||||||||||
Human | Mouse | |||||||||||||
Entrez | 80329 | 77777 | ||||||||||||
Ensembl | ENSG00000111981 | n/a | ||||||||||||
Uniprot | Q9BZM6 | n/a | ||||||||||||
Refseq | NM_025218 (mRNA) NP_079494 (protein) |
NM_029975 (mRNA) NP_084251 (protein) |
||||||||||||
Location | Chr 6: 150.33 - 150.34 Mb | n/a | ||||||||||||
Pubmed search | [1] | [2] |
UL16 binding protein 1, also known as ULBP1, is a human gene.[1]
[edit] References
[edit] Further reading
- Cerwenka A, Lanier LL (2004). "NKG2D ligands: unconventional MHC class I-like molecules exploited by viruses and cancer.". Tissue Antigens 61 (5): 335-43. PMID 12753652.
- Cosman D, Müllberg J, Sutherland CL, et al. (2001). "ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor.". Immunity 14 (2): 123-33. PMID 11239445.
- Steinle A, Li P, Morris DL, et al. (2001). "Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family.". Immunogenetics 53 (4): 279-87. PMID 11491531.
- Sutherland CL, Chalupny NJ, Schooley K, et al. (2002). "UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells.". J. Immunol. 168 (2): 671-9. PMID 11777960.
- Radosavljevic M, Cuillerier B, Wilson MJ, et al. (2002). "A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3.". Genomics 79 (1): 114-23. doi: . PMID 11827464.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899-903. doi: . PMID 12477932.
- Dunn C, Chalupny NJ, Sutherland CL, et al. (2003). "Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity.". J. Exp. Med. 197 (11): 1427-39. doi: . PMID 12782710.
- Rölle A, Mousavi-Jazi M, Eriksson M, et al. (2003). "Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein.". J. Immunol. 171 (2): 902-8. PMID 12847260.
- Eleme K, Taner SB, Onfelt B, et al. (2004). "Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D.". J. Exp. Med. 199 (7): 1005-10. doi: . PMID 15051759.
- Bacon L, Eagle RA, Meyer M, et al. (2004). "Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D.". J. Immunol. 173 (2): 1078-84. PMID 15240696.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121-7. doi: . PMID 15489334.
- López-Soto A, Quiñones-Lombraña A, López-Arbesú R, et al. (2006). "Transcriptional regulation of ULBP1, a human ligand of the NKG2D receptor.". J. Biol. Chem. 281 (41): 30419-30. doi: . PMID 16901903.